Article
Effect of ATG-F on B-cell reconstitution after hematopoietic stem cell transplantation.
European journal of haematology - 1 Dec 2015
Roll Petra, Muhammad Khalid, Stuhler Gernot, Grigoleit Ulrich, Einsele Hermann, Tony Hans-Peter
Abstract excerpt
Antithymocyte globulin Fresenius (ATG-F) is used before hematopoietic stem cell transplantation to prevent graft rejection and graft-versus-host disease in patients with HLA-matched unrelated donors or mismatched volunteers. However, little is known about the effect of ATG-F on the reconstitution of B-cell subsets. Sixty-seven patients were longitudinally studied at day 15, day 30, and then monthly after...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
